Reclast FDA Approval History
FDA Approved: Yes (First approved April 16, 2007)
Brand name: Reclast
Generic name: zoledronic acid
Dosage form: Injection
Previous Name: Aclasta
Treatment for: Paget's Disease, Prevention of Osteoporosis, Prevention of Fractures
Reclast (zoledronic acid) is a bisphosphonate indicated for the treatment for Paget's disease, postmenopausal osteoporosis and prevention of fractures.
Development timeline for Reclast
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.